BioMerieux (BIMp)
Euronext Paris • Healthcare
April 20, 2026 at 10:20 UTC
About BioMerieux
BioMerieux is an in vitro diagnostics company that designs systems, reagents, and software used in clinical laboratories and public-health settings. The portfolio supports microbiology, immunoassay, and molecular workflows, and products are developed to fit validation and quality routines in regulated environments. Manufacturing and field support operate under a single quality framework, and documentation is written for accreditation bodies as well as lab managers. Country organizations handle market access and training while core engineering and medical information remain centralized. The company’s stance in the healthcare ecosystem is method first: evidence, labeling, and service are kept in step so laboratories can adopt platforms without rewriting daily practice. Activity spans many regions with logistics tuned to cold-chain and service windows.
Analyst Ratings
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Technical Indicators
BioMerieux's Technical Indicators Summary
BIM is technically bearish with price below short‑ and long‑term moving averages, negative momentum and a below‑neutral RSI that together indicate sustained selling pressure. MACD is negative and the 200‑period EMA sits well above the market, underscoring longer‑term weakness, while ADX shows only moderate trend strength and ATR points to contained volatility. On‑balance volume is not strongly supportive of a reversal, and the pivot lies above price as a nearby resistance marker. Technical takeaway: Bearish — broad moving‑average weakness with negative momentum and limited recovery volume.
| Indicator | Value |
|---|---|
RSI (14) | 41.98 |
Stochastic %K (14, 3, 3) | 41.60 |
CCI (20) | -65.30 |
WPR (14) | -70.68 |
Momentum (10) | -3.70 |
MFI | 52.73 |
MACD Level (12, 26) | -0.90 |
Bollinger Bands | $88.50 - $93.48 |
ATR (14) | $1.91 (2.12%) |
ADX (14) | 21.60 |
OBV | -835,122 |
Classic Pivot Point | $91.30 |
Fibonacci Pivot Point | $91.30 |
Simple Moving Averages | $90.99 - $108.08(5 indicators) |
Exponential Moving Averages | $91.07 - $105.79(5 indicators) |
Get premium market insights delivered directly to your inbox.
Today's Snapshot
The bell brought only a slight negative bias, with BIMp edging -0.11% lower to open at 91.00 versus 91.10. The session begins with a soft sector rise of 1.49%, nudging the backdrop in a constructive direction. BIMp opens modestly softer amid a broadly rising sector, keeping a constructive backdrop for the session.
Price Change
from €91.35 close
-€1.27
Trading Volume
Above avg 131.7K
179K
vs S&P 500 Today
Underperforming Market
-1.05%
52-Week Position
Near lows
9%
Updated: April 20, 2026 at 09:33 UTC